Just a moment...
Press 'Enter' to add multiple search terms. Rules for Better Search
Use comma for multiple locations.
---------------- For section wise search only -----------------
Accuracy Level ~ 90%
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
No Folders have been created
Are you sure you want to delete "My most important" ?
NOTE:
Press 'Enter' after typing page number.
Press 'Enter' after typing page number.
Don't have an account? Register Here
Press 'Enter' after typing page number.
Issues: (i) Whether the product 'Face-to-Face' cream was classifiable as a medicament under Chapter 30 of the Central Excise Tariff Act, 1985 or as a cosmetic preparation under Chapter 33 of that Act. (ii) Whether the provisional assessment under Rule 9B of the Central Excise Rules, 1944 could be treated as provisional only for classification purposes.
Issue (i): Whether the product 'Face-to-Face' cream was classifiable as a medicament under Chapter 30 of the Central Excise Tariff Act, 1985 or as a cosmetic preparation under Chapter 33 of that Act.
Analysis: Classification depended on the main use of the product and the manner in which it was held out in the market. Therapeutic or prophylactic properties were not enough by themselves to place the product in Chapter 30. If the principal use was care of the skin and any pharmaceutical effect was only subsidiary, Chapter 33 would apply. The product literature, prescription evidence, duration of use, and the common perception of the product were relevant to determine whether its therapeutic use was the main use or merely incidental.
Conclusion: The classification issue was not finally decided on merits and was sent back for fresh determination.
Issue (ii): Whether the provisional assessment under Rule 9B of the Central Excise Rules, 1944 could be treated as provisional only for classification purposes.
Analysis: A provisional assessment made under Rule 9B remained provisional for all purposes. The plea that the dispute ceased to be provisional because it involved classification was not accepted as a bar to further consideration by the original authority.
Conclusion: The provisional nature of the assessment continued for all purposes and did not assist the assessee to avoid re-determination.
Final Conclusion: The appeal succeeded for the Revenue only to the extent that the earlier orders were set aside and the matter was remitted for fresh decision on classification and consequential duty liability.
Ratio Decidendi: In classification disputes, a product is placed in Chapter 30 only if therapeutic or prophylactic use is its main use, while subsidiary medicinal effects do not displace classification under Chapter 33; a provisional assessment remains provisional for all purposes under Rule 9B.